FAQ on Intelligent Bio Solutions Inc.'s FDA Clearance Progress for Fingerprint Drug Testing

What is the Intelligent Fingerprinting Drug Screening System?

The Intelligent Fingerprinting Drug Screening System is a non-invasive device that detects recent drug use through fingerprint sweat, offering speed, portability, and integration into safety-critical environments.

Why is the FDA clearance for this system significant?

FDA clearance would allow Intelligent Bio Solutions Inc. to launch its drug screening system in the U.S. by 2025, expanding its global footprint and addressing growing demand for non-invasive drug testing solutions.

How accurate is the Intelligent Fingerprinting Drug Screening System?

Validation studies included in the FDA 510(k) submission showed the system has a 94.1% accuracy in detecting opiates through fingerprint sweat.

Where is the Intelligent Fingerprinting Drug Screening System currently available?

The system is already active in 24 countries, with over 450 commercial accounts globally, including industries like logistics, mining, retail, and marine operations.

When is the U.S. launch of the Intelligent Fingerprinting Drug Screening System expected?

The U.S. launch of the system is expected in 2025, as the company progresses through the FDA clearance process.

What are the benefits of the Intelligent Fingerprinting Drug Screening System?

The system offers a non-invasive, rapid, and portable solution for drug testing, capable of integrating into various safety-critical environments, making it highly versatile and efficient.

How does Intelligent Bio Solutions Inc. plan to support its U.S. market entry?

The company is expanding its distributor network to support localized growth ahead of its U.S. market entry, ensuring widespread availability and adoption.

Where can I find more information about Intelligent Bio Solutions Inc. and its developments?

The latest news and updates relating to INBS are available in the company’s newsroom at https://ibn.fm/INBS.